Overview
Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by SARS-associated coronaviruses, betacoronaviruses that infect the lower respiratory tract and can progress to severe pneumonia and acute respiratory distress. The original SARS-CoV emerged in 2002, and the closely related SARS-CoV-2 emerged in 2019 as the cause of COVID-19; both are enveloped, positive-sense RNA viruses whose spike glycoprotein mediates receptor binding and entry and serves as a key target for diagnostics, vaccines, and evolutionary analysis. Transmission occurs largely through respiratory droplets and close contact, and the high transmissibility and clinical severity of these viruses have made them central concerns of public health, demanding surveillance, molecular characterization of variants, vaccination, and control measures. Research relevant to this area includes the molecular evolutionary characteristics of SARS-CoV-2 based on spike glycoprotein gene analysis, viral kinetics in mild COVID-19 patients under chloroquine regimens, vaccine efficacy and post-vaccination seroprevalence, molecular evolution and pathogenesis of SARS-CoV-2, screening for variants of concern using rapid-antigen-test residual samples, spike-protein effects on interferon and cytokine gene expression, and strategies to generate herd immunity. Such studies span virology, molecular epidemiology, and prevention. The journal publishes peer-reviewed research on SARS coronaviruses, their molecular evolution and pathogenesis, and the public-health response to coronavirus disease.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Anti-COVID19 Vaccine among Workers at the Local Health Authority of Rieti (Italy). Study on the Vaccine Efficacy and Seroprevalence Post-Vaccination
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
Molecular Evolution of the Novel Coronavirus SARS-CoV-2
SARS-Corona Virus-2 Origin and Treatment, From Coffee to Coffee: A Double-Edged Sword
SARS-CoV-2 affected cells Pathogeny and Therapy
Use of the Remaining Sample from the Panbio COVID-19 Antigen Rapid Test Device for the Molecular Screening of the SARS-CoV-2 Variant of Concern B.1.1.7
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
Exponential Parsimony to Generate Herd Immunity Against SARS- CoV2 Cybernetically Restricting Doxastic and Desiderative Logics
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Success for Big Infectious Disease Reimbursement Policy in China
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
How this research is being cited
The 12 articles above have been cited 14 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
R. Paulino-Ramírez et al. · 2023 · International Journal of Environmental Research and Public Health
-
Qi Li et al. · 2023 · Biosensors
-
2023 · International Journal of Environmental Research and Public Health
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
-
Shengzhe Zhou et al. · 2022 · Microbiology Research
-
2021 ·
-
2021 · SN Computer Science
A sample of recent works citing this journal's research on SARS, linking to each citing work.